| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5928502 | American Heart Journal | 2014 | 7 Pages |
Abstract
The need to clarify the uncertainty of the role of supplemental oxygen therapy in the setting of suspected AMI is urgent. The DETO2X-AMI trial is designed and powered to address this important issue and may have a direct impact on future recommendations.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Robin MD, Stefan K. MD, PhD, Leif MD, PhD, Nils MD, PhD, Mats MD, PhD, Bertil MD, PhD, Ollie PhD, Ulf MD, PhD, David MD, PhD, Johan MD, PhD, Tomas MD, PhD,